The Workplace-Based Hypertension Management Program
The Workplace-Based, Multicomponent Hypertension Management Program in Patients Aged 18-60 Years: A Randomized Controlled Trial
1 other identifier
interventional
512
1 country
1
Brief Summary
This study aims to evaluate the effectiveness of a workplace-based, multicomponent hypertension management program for newly diagnosed patients. Investigators will recruit 512 participants (256 pairs) from the Kailuan Study in Tangshan, China. Participants will be randomly assigned to receive a Workplace-based Multicomponent Hypertension Management Program or Standard Workplace Health Management. The primary objective is to assess improvements in blood pressure control and hypertension-related health behaviors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jan 2026
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2025
CompletedFirst Posted
Study publicly available on registry
December 4, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
December 4, 2025
November 1, 2025
1 year
November 19, 2025
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in systolic and diastolic blood pressure
Change in systolic and diastolic blood pressure from baseline to 12 months
up to 12 months
Secondary Outcomes (3)
Changes in hypertension-related health behaviors
up to 12 months
Change in body mass index (BMI)
up to 12 months
Work productivity and quality of life scores
up to 12 months
Study Arms (2)
Standard Workplace Health Management
ACTIVE COMPARATORRoutine workplace health education and management according to current guidelines, including routine health education, standard hypertension counseling, and usual workplace health services.
Workplace-based Multicomponent Hypertension Management Program
EXPERIMENTALMulticomponent strategies, including default scheduling of BP monitoring and counseling sessions, personalized reminders via workplace digital systems, social comparison feedback using anonymized peer data, small incentives and commitment devices.
Interventions
Multicomponent strategies, including default scheduling of BP monitoring and counseling sessions, personalized reminders via workplace digital systems, social comparison feedback using anonymized peer data, small incentives and commitment devices.
Routine workplace health education and management according to current guidelines, including routine health education, standard hypertension counseling, and usual workplace health services.
Eligibility Criteria
You may qualify if:
- Adults aged 18-60 years
- Newly diagnosed hypertension (per 2024 Chinese hypertension guideline criteria)
- Employed in Kailuan Group workplace settings
- Able to provide informed consent
You may not qualify if:
- Severe cardiovascular or renal disease at baseline
- Psychiatric disorders affecting compliance
- Pregnant or lactating women
- Participation in other intervention trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yan-Feng Zhou
Nanning, Guangxi, 530021, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- School of Public Health
Study Record Dates
First Submitted
November 19, 2025
First Posted
December 4, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Last Updated
December 4, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
De-identified individual participant data will be available upon reasonable request after publication of main trial results.